Kramer Levin adds two life sciences partners in New York

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Kramer Levin adds two life sciences partners in New York

Brian Slater and Gregory Sephton have joined Kramer Levin Naftalis & Frankel in New York. They were previously at Fitzpatrick Cella Harper & Scinto

kramer-levin-adds-two.jpg

They both have more than 20 years of experience handling patent litigation involving a broad range of technologies in the life sciences.

Slater (top right) has served as lead counsel to companies such as Gilead, Merck, and Sanofi.

Sephton (bottom right) has been involved in litigating and trying patent cases for a number of technology leaders, including Emory University, Astra Zeneca, Novartis and Warner Chilcott.

The move follows Kramer Levin’s recent hiring of Christine Willgoos, a life sciences patent litigator who came from Paul Hastings.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Schwitulla is the head of litigation management at Nokia in Germany
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article